常染色体显性多囊肾病患者脑动脉瘤:管理方法比较
该单中心回顾性分析纳入2000至2016年45例常染色体显性多囊肾病(ADPKD)患者的71个颅内动脉瘤,比较观察、开颅手术和血管内治疗的结果。观察的22个动脉瘤在136年临床随访中无一破裂;治疗后不良神经功能结局和急性肾损伤仅见于蛛网膜下腔出血(SAH)患者,且与治疗方式无关。
要点
- 观察的22个动脉瘤在136年临床随访中均未破裂。
- 不良神经功能结局仅见于SAH患者(17% SAH vs 0% 择期,P = .06)。
- 急性肾损伤与SAH表现相关(22% SAH vs 0% 择期,P = .05),与治疗方式无关。
核心结论
- 不良结局仅见于破裂表现的患者,但在不同治疗方式之间相当。
- 筛查仅选择性进行,64%(7/11)的SAH患者既往已知患有ADPKD。
研究设计与样本
- 单中心回顾性分析,纳入2000年至2016年所有ADPKD合并颅内动脉瘤的患者。
- 共识别45例ADPKD患者,携带71个动脉瘤,其中11例表现为蛛网膜下腔出血(SAH)。
主要发现
- 观察管理的22个动脉瘤在136年临床随访中无一破裂。
- 35个动脉瘤接受开颅手术治疗,14个接受血管内治疗。
- 治疗后不良神经功能结局(改良Rankin量表>2)仅见于SAH患者(17% SAH vs 0% 择期,P = .06)。
- 急性肾损伤(AKI)与SAH表现显著相关(22% SAH vs 0% 择期,P = .05)。
- 程序并发症和AKI均与治疗方式无关。
关键数值与推荐
- 在已知颅内动脉瘤患者175年影像学随访中,发现8个新发动脉瘤,其中3个接受治疗。
- 11例SAH患者中,7例在既往已知ADPKD的情况下破裂,其中2例曾接受血管造影筛查,5例未筛查。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is a risk factor for formation of intracranial aneurysms (IAs), though the ideal screening and treatment strategies in this population are unclear. OBJECTIVE: To report outcomes of observation, open surgical, or endovascular management of ruptured and unruptured aneurysms in patients with ADPKD. METHODS: We performed a retrospective analysis of all patients with ADPKD and IAs at a single center from 2000 to 2016. RESULTS: Forty-five patients with ADPKD harboring 71 aneurysms were identified, including 11 patients with subarachnoid hemorrhage (SAH). Of 22 aneurysms managed with observation, none ruptured in 136 yr of clinical follow-up. Thirty-five aneurysms were treated with open surgery and 14 with an endovascular approach. Among treated aneurysms, poor neurologic outcome (modified Rankin scale >2) was seen only in patients presenting with SAH (17% SAH vs 0% elective, P = .06). Acute kidney injury (AKI) was also significantly associated with SAH presentation (22% SAH vs 0% elective, P = .05). Neither procedural complications nor AKI were associated with treatment modality. Among 175 yr of radiographic follow-up in patients with known IAs, 8 de novo aneurysms were found, including 3 that were treated. Of 11 patients with SAH, 7 ruptured in the setting of previously known ADPKD, including 2 with prior angiographic screening and 5 without screening. CONCLUSION: Poor outcomes occurred only with ruptured presentation but were equivalent between treatment modalities. Screening is performed only selectively, and 64% (7 of 11) of patients presenting with SAH had previously known ADPKD.
引用
- Wilkinson DA, Heung M, Deol A, et al. Cerebral Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Comparison of Management Approaches. Neurosurgery. 2019. PMID: 30060240. doi:10.1093/neuros/nyy336
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。